VERASTEM INC's ticker is VSTM and the CUSIP is 92337C104. A total of 125 filers reported holding VERASTEM INC in Q3 2020. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $192,471 | +90688.2% | 463,751 | -12.0% | 0.00% | – |
| Q4 2022 | $212 | -100.0% | 527,214 | -26.8% | 0.00% | – |
| Q3 2022 | $612,000 | -61.4% | 719,795 | -47.3% | 0.00% | -100.0% |
| Q2 2022 | $1,586,000 | -39.5% | 1,367,051 | -26.5% | 0.00% | 0.0% |
| Q1 2022 | $2,623,000 | -47.0% | 1,859,953 | -23.0% | 0.00% | 0.0% |
| Q4 2021 | $4,950,000 | -29.6% | 2,414,824 | +5.8% | 0.00% | -50.0% |
| Q3 2021 | $7,027,000 | -4.7% | 2,281,533 | +25.9% | 0.00% | 0.0% |
| Q2 2021 | $7,375,000 | +150.6% | 1,812,160 | +52.1% | 0.00% | +100.0% |
| Q1 2021 | $2,943,000 | +282.7% | 1,191,490 | +230.1% | 0.00% | – |
| Q4 2020 | $769,000 | +99.7% | 360,934 | +13.4% | 0.00% | – |
| Q3 2020 | $385,000 | -39.9% | 318,169 | -14.6% | 0.00% | – |
| Q2 2020 | $641,000 | -59.5% | 372,683 | -37.9% | 0.00% | -100.0% |
| Q1 2020 | $1,583,000 | +91.4% | 599,694 | -2.8% | 0.00% | – |
| Q4 2019 | $827,000 | -4.4% | 616,864 | -13.7% | 0.00% | – |
| Q3 2019 | $865,000 | -42.9% | 714,997 | -28.8% | 0.00% | -100.0% |
| Q2 2019 | $1,515,000 | -52.8% | 1,003,613 | -7.5% | 0.00% | 0.0% |
| Q1 2019 | $3,212,000 | -11.9% | 1,085,135 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $3,646,000 | -7.9% | 1,085,135 | +98.8% | 0.00% | 0.0% |
| Q3 2018 | $3,958,000 | +5.9% | 545,942 | +0.5% | 0.00% | +100.0% |
| Q2 2018 | $3,736,000 | +130.0% | 542,977 | -0.4% | 0.00% | 0.0% |
| Q1 2018 | $1,624,000 | -18.3% | 545,097 | -15.8% | 0.00% | 0.0% |
| Q4 2017 | $1,988,000 | -24.7% | 647,443 | +15.2% | 0.00% | 0.0% |
| Q3 2017 | $2,641,000 | +317.9% | 561,969 | +93.9% | 0.00% | – |
| Q2 2017 | $632,000 | +742.7% | 289,828 | +697.6% | 0.00% | – |
| Q1 2017 | $75,000 | +97.4% | 36,336 | +7.7% | 0.00% | – |
| Q4 2016 | $38,000 | -22.4% | 33,748 | -8.4% | 0.00% | – |
| Q3 2016 | $49,000 | +2.1% | 36,855 | 0.0% | 0.00% | – |
| Q2 2016 | $48,000 | -17.2% | 36,855 | 0.0% | 0.00% | – |
| Q1 2016 | $58,000 | -15.9% | 36,855 | 0.0% | 0.00% | – |
| Q4 2015 | $69,000 | +4.5% | 36,855 | 0.0% | 0.00% | – |
| Q3 2015 | $66,000 | -75.4% | 36,855 | +3.7% | 0.00% | – |
| Q2 2015 | $268,000 | -26.0% | 35,555 | 0.0% | 0.00% | – |
| Q1 2015 | $362,000 | +382.7% | 35,555 | +334.1% | 0.00% | – |
| Q4 2014 | $75,000 | +7.1% | 8,191 | 0.0% | 0.00% | – |
| Q3 2014 | $70,000 | -5.4% | 8,191 | 0.0% | 0.00% | – |
| Q2 2014 | $74,000 | – | 8,191 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,865,000 | $3,823,000 | 1.61% |
| Altium Capital Management LP | 2,253,000 | $4,619,000 | 1.27% |
| BVF INC/IL | 17,062,158 | $34,977,000 | 1.27% |
| MPM BioImpact LLC | 3,271,532 | $6,707,000 | 1.22% |
| Opaleye Management Inc. | 2,325,000 | $4,766,000 | 1.01% |
| Soleus Capital Management, L.P. | 1,644,500 | $3,371,000 | 0.34% |
| Baker Brothers Advisors | 21,491,630 | $44,058,000 | 0.21% |
| Ikarian Capital, LLC | 637,371 | $1,308,000 | 0.20% |
| Samalin Investment Counsel, LLC | 90,000 | $185,000 | 0.11% |
| Parkman Healthcare Partners LLC | 183,332 | $376,000 | 0.08% |